Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex interacting protein family member B3 (NPIPB3) is a protein-coding gene belonging to a primate-specific family of nuclear pore complex-interacting proteins. It is predicted to localize to the nuclear envelope and may play a role in nuclear envelope function, as well as potentially participating in cellular immune responses to viral proteins, such as SARS-CoV-2 open reading frame 6. There are few characterized biological or therapeutic roles, and little direct evidence supporting its use or modulation as a clinical drug target[1][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex interacting protein family member B3 (NPIPB3).